Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CDMO
CDMO logo

CDMO News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CDMO News

Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners

Feb 05 2025Newsfilter

Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand

Jan 21 2025Newsfilter

Insider Sale: Chief Operations Officer of $CDMO (CDMO) Sells 200 Shares

Jan 14 2025NASDAQ.COM

RBC Capital Sticks to Its Hold Rating for Avid Bioservices (CDMO)

Jan 09 2025Business Insider

Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

Jan 08 2025Newsfilter

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CDMO, AE, SUM, BCOV on Behalf of Shareholders

Jan 07 2025PRnewswire

AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMO

Jan 07 2025Businesswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, CDMO, ROIC, SUM on Behalf of Shareholders

Jan 05 2025Globenewswire

CDMO Events

02/10 07:13
Avid Bioservices launches new company website design
Avid Bioservices announced the launch of its new corporate website. The new site, which can be visited at www.avidbio.com, combines Avid's elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers. The reimagined Avid website captures the company's brand through the tagline, "Discover the Avid effect.", helping educate visitors on the differentiation that positions the company as one of the industry's leading, most trusted biologics CDMOs.
01/30 15:32
Avid Bioservices' stockholders approve transaction with GHO and Ampersand
Avid Bioservices announced that Avid stockholders voted to approve the transaction with GHO Capital Partners and Ampersand Capital Partners at the Avid special meeting of stockholders held earlier today. "We thank our stockholders for their support through our time as a public company and the duration of this process," said Nick Green, president and CEO of Avid Bioservices. "We look forward to completing the transaction and delivering significant, immediate and certain cash value to our stockholders." With today's stockholder approval, all closing conditions, other than those to be satisfied at closing, have been met and regulatory approvals have been received, and the Company therefore expects the transaction to close in the coming days. The final, certified voting results for the Special Meeting will be provided in a Form 8-K filed with the U.S. Securities and Exchange Commission.
01/21 07:21
Avid Bioservices says ISS, Glass Lewis recommend vote 'FOR' transaction
Avid Bioservices announced that leading independent proxy advisory firms Institutional Shareholder Services and Glass Lewis & Co. recommend that Avid stockholders vote "FOR" the Company's pending transaction with GHO Capital Partners and Ampersand Capital Partners. Nick Green, president and CEO of Avid Bioservices, said, "We are pleased that ISS and Glass Lewis recognize the premium value of the GHO and Ampersand transaction for Avid stockholders, as well as the process run by our Board of Directors to ensure we are maximizing value. We encourage our stockholders to vote FOR our transaction with GHO and Ampersand today."

CDMO Monitor News

No data

No data

CDMO Earnings Analysis

No Data

No Data

People Also Watch